147 related articles for article (PubMed ID: 21697888)
1. Huntingtin-interacting protein 1: a Merkel cell carcinoma marker that interacts with c-Kit.
Ames HM; Bichakjian CK; Liu GY; Oravecz-Wilson KI; Fullen DR; Verhaegen ME; Johnson TM; Dlugosz AA; Ross TS
J Invest Dermatol; 2011 Oct; 131(10):2113-20. PubMed ID: 21697888
[TBL] [Abstract][Full Text] [Related]
2. Association of Merkel cell polyomavirus infection with tumor p53, KIT, stem cell factor, PDGFR-alpha and survival in Merkel cell carcinoma.
Waltari M; Sihto H; Kukko H; Koljonen V; Sankila R; Böhling T; Joensuu H
Int J Cancer; 2011 Aug; 129(3):619-28. PubMed ID: 20949558
[TBL] [Abstract][Full Text] [Related]
3. KIT receptor activation by autocrine and paracrine stem cell factor stimulates growth of merkel cell carcinoma in vitro.
Krasagakis K; Fragiadaki I; Metaxari M; Krüger-Krasagakis S; Tzanakakis GN; Stathopoulos EN; Eberle J; Tavernarakis N; Tosca AD
J Cell Physiol; 2011 Apr; 226(4):1099-109. PubMed ID: 20857409
[TBL] [Abstract][Full Text] [Related]
4. Co-expression of KIT receptor and its ligand stem cell factor in Merkel cell carcinoma.
Krasagakis K; Kruger-Krasagakis S; Eberle J; Tsatsakis A; Tosca AD; Stathopoulos EN
Dermatology; 2009; 218(1):37-43. PubMed ID: 19001805
[TBL] [Abstract][Full Text] [Related]
5. Expression of VEGF-A/C, VEGF-R2, PDGF-alpha/beta, c-kit, EGFR, Her-2/Neu, Mcl-1 and Bmi-1 in Merkel cell carcinoma.
Brunner M; Thurnher D; Pammer J; Geleff S; Heiduschka G; Reinisch CM; Petzelbauer P; Erovic BM
Mod Pathol; 2008 Jul; 21(7):876-84. PubMed ID: 18408656
[TBL] [Abstract][Full Text] [Related]
6. c-kit expression in primary and metastatic merkel cell carcinoma.
Feinmesser M; Halpern M; Kaganovsky E; Brenner B; Fenig E; Hodak E; Sulkes J; Okon E
Am J Dermatopathol; 2004 Dec; 26(6):458-62. PubMed ID: 15618926
[TBL] [Abstract][Full Text] [Related]
7. CD117 (KIT receptor) expression in Merkel cell carcinoma.
Su LD; Fullen DR; Lowe L; Uherova P; Schnitzer B; Valdez R
Am J Dermatopathol; 2002 Aug; 24(4):289-93. PubMed ID: 12142606
[TBL] [Abstract][Full Text] [Related]
8. Growth and characterization of a cell line from a human primary neuroendocrine carcinoma of the skin (Merkel cell carcinoma) in culture and as xenograft.
Krasagakis K; Almond-Roesler B; Geilen C; Fimmel S; Krengel S; Chatzaki E; Gravanis A; Orfanos CE
J Cell Physiol; 2001 Jun; 187(3):386-91. PubMed ID: 11319762
[TBL] [Abstract][Full Text] [Related]
9. Huntingtin interacting protein 1 as a histopathologic adjunct in the diagnosis of Merkel cell carcinoma.
Marghalani S; Feller JK; Mahalingam M; Mirzabeigi M
Int J Dermatol; 2015 Jun; 54(6):640-7. PubMed ID: 25070010
[TBL] [Abstract][Full Text] [Related]
10. Phospho-STAT5B Expression Is a Prognostic Marker for Merkel Cell Carcinoma.
Fujimura T; Furudate S; Kambayahsi Y; Kakizaki A; Yamamoto Y; Okuhira H; Fujimoto N; Aiba S
Anticancer Res; 2017 May; 37(5):2335-2341. PubMed ID: 28476799
[TBL] [Abstract][Full Text] [Related]
11. CD99 expression in Merkel cell carcinoma: a case series with an unusual paranuclear dot-like staining pattern.
Rajagopalan A; Browning D; Salama S
J Cutan Pathol; 2013 Jan; 40(1):19-24. PubMed ID: 23145531
[TBL] [Abstract][Full Text] [Related]
12. Specific analysis of KIT and PDGFR-alpha expression and mutational status in Merkel cell carcinoma.
Swick BL; Srikantha R; Messingham KN
J Cutan Pathol; 2013 Jul; 40(7):623-30. PubMed ID: 23621836
[TBL] [Abstract][Full Text] [Related]
13. SATB2 is expressed in Merkel cell carcinoma.
Fukuhara M; Agnarsdóttir M; Edqvist PH; Coter A; Ponten F
Arch Dermatol Res; 2016 Aug; 308(6):449-54. PubMed ID: 27262585
[TBL] [Abstract][Full Text] [Related]
14. Clinicopathological and immunohistochemical analysis of 20 cases of Merkel cell carcinoma in search of prognostic markers.
Llombart B; Monteagudo C; López-Guerrero JA; Carda C; Jorda E; Sanmartín O; Almenar S; Molina I; Martín JM; Llombart-Bosch A
Histopathology; 2005 Jun; 46(6):622-34. PubMed ID: 15910593
[TBL] [Abstract][Full Text] [Related]
15. Prognostic relevance of high atonal homolog-1 expression in Merkel cell carcinoma.
Gambichler T; Mohtezebsade S; Wieland U; Silling S; Höh AK; Dreißigacker M; Schaller J; Schulze HJ; Oellig F; Kreuter A; Stockfleth E; Stücker M; Bechara FG; Becker JC
J Cancer Res Clin Oncol; 2017 Jan; 143(1):43-49. PubMed ID: 27624714
[TBL] [Abstract][Full Text] [Related]
16. Expression of c-Kit and its ligand SCF in primary uveal melanoma.
Lüke J; Wegner J; Wegner R; Nassar K; Tatar O; Rohrbach JM; Hilgers RD; Lüke M; Grisanti S
Eur J Ophthalmol; 2011; 21(5):615-24. PubMed ID: 21279973
[TBL] [Abstract][Full Text] [Related]
17. Histological Features, p53, c-Kit, and Poliomavirus Status and Impact on Survival in Merkel Cell Carcinoma Patients.
Husein-ElAhmed H; Ramos-Pleguezuelos F; Ruiz-Molina I; Civico-Amat V; Solis-García E; Galán-Gutierrez M; Ruiz-Villaverde R
Am J Dermatopathol; 2016 Aug; 38(8):571-9. PubMed ID: 27442046
[TBL] [Abstract][Full Text] [Related]
18. Merkel cell carcinoma: correlation of KIT expression with survival and evaluation of KIT gene mutational status.
Andea AA; Patel R; Ponnazhagan S; Kumar S; DeVilliers P; Jhala D; Eltoum IE; Siegal GP
Hum Pathol; 2010 Oct; 41(10):1405-12. PubMed ID: 20594584
[TBL] [Abstract][Full Text] [Related]
19. A new immunohistochemical marker, insulinoma-associated protein 1 (INSM1), for Merkel cell carcinoma: Evaluation of 24 cases.
Leblebici C; Yeni B; Savli TC; Aydın Ö; Güneş P; Cinel L; Şimşek BÇ; Yıldız P; Tuncel D; Kayahan S
Ann Diagn Pathol; 2019 Jun; 40():53-58. PubMed ID: 31031215
[TBL] [Abstract][Full Text] [Related]
20. Identification of the M541L sequence variation of the transmembrane KIT domain in Merkel cell carcinoma.
Krasagakis K; Metaxari M; Zervou M; Stathopoulos EN; Eberle J; Kanitakis J; Georgoulias V; Krüger-Krasagakis S; Tavernarakis N; Tosca AD
Anticancer Res; 2011 Mar; 31(3):807-11. PubMed ID: 21498700
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
